Skip to main content
logo
SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.810
+0.190 (5.25%)
At close: Aug 25, 2026, 4:00 PM EDT
3.880
+0.070 (1.84%)
After-hours: Aug 25, 2026, 4:51 PM EDT

SAB Biotherapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
86
Market Cap
346.66M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 20241.32M-916.58K-40.94%
Dec 31, 20232.24M-21.67M-90.63%
Dec 31, 202223.90M-36.97M-60.73%
Dec 31, 202160.88M5.64M10.21%
Dec 31, 202055.24M51.80M1,504.91%
Dec 31, 20193.44M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Vanda Pharmaceuticals215.72M
Agenus132.69M
Sutro Biopharma45.70M
Orchestra BioMed Holdings31.98M
Abeona Therapeutics25.52M
ProQR Therapeutics21.05M
Opus Genetics9.86M
YD Bio510.36K
Revenue Rankings

SABS News

More News